Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 20 | 17 | 17 | 29 | 14 |
| Accounts receivable | -8 | 63 | -26 | -40 | 52 |
| Other Working Capital | 247 | -195 | 117 | 283 | 29 |
| Other Operating Activity | -925 | -755 | -822 | -722 | -887 |
| Operating Cash Flow | $-667 | $-871 | $-713 | $-449 | $-791 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -4 | 0 | -5 | -1 |
| Purchase Sale Intangibles | -54 | -28 | -18 | -61 | -11 |
| Investing Cash Flow | $-54 | $-32 | $-18 | $-66 | $-12 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 500 | 0 | N/A | -36 | -915 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 3,987 |
| Financing Cash Flow | $500 | $0 | $0 | $-36 | $3,072 |
| Beginning Cash Position | 342 | 1,245 | 1,976 | 2,527 | 258 |
| End Cash Position | 122 | 342 | 1,245 | 1,976 | 2,527 |
| Net Cash Flow | $-221 | $-903 | $-731 | $-552 | $2,269 |
| Free Cash Flow | |||||
| Operating Cash Flow | -667 | -871 | -713 | -449 | -791 |
| Capital Expenditure | -54 | -32 | -18 | -66 | -12 |
| Free Cash Flow | -721 | -903 | -731 | -516 | -803 |